About OPIS
OPIS was founded in 1998 by medical doctors from the Pharma Industry and is a Global clinical CRO with 25 years of experience in a wide range of therapeutic areas. OPIS provides full-service, 360° clinical trial support from study concept creation and protocol development to full project execution, study data handling and up to study closure, analysis, and reporting. We manage Phase I-IV, interventional, non-interventional and medical devices studies on an international level. In addition, OPIS also manages pre- and post-marketing clinical investigations for medical and diagnostic devices, nutraceutical, and food supplement studies.
Our qualified, fully trained, and dedicated staff has managed 1470 studies to date.
OPIS’s strength lies in its people and its specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff that ensure high quality project execution, with global coverage.
Our mission is to increase the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system... etc.
OPIS is committed to continuous growth and expansion, while currently we have affiliates in 17 countries around the world.
For more information, visit www.opisresearch.com
|
|
|
201-500 employees
View all OPIS employees
|
|
Research Services
|
|
Via Matteotti, 10, Desio, Monza Brianza 20832, IT
|
|
1998
|
|
Pharmacovigilance, Cro, Project Control, Clinical Development, Quality Assurance, Regulatory, Data Management, Clinical Research, Other Services, Medical Monitoring, Observational Research, Post Market Studies, Early Phase Trials, Preclinical And Drug Development Consultancy, Real World Evidence Studies, Statistical Analysis And Consultancy, Staudy Management And Monitoring, Trials Start-Up, E-Clinical Platform, Investigator Initiated Trials, Medical Affairs And Medical Writing, Medical Device Clinical Investigations, Nutraceuti
|
OPIS Alternatives
Frequently Asked Questions about OPIS
Laura Ambrosoli is the CEO of OPIS. To contact Laura Ambrosoli email at [email protected].
The decision makers in OPIS are Alia Hamiduddin, Carlo Torri, Fabio Romero, etc. Click to Find OPIS decision makers emails.
OPIS Staff Directory
Search OPIS Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
